Personal profile
Biography
I am a dedicated and compassionate medical oncologist with a particular interest in genitourinary and
gastrointestinal cancers. I have five years of Consultant Medical Oncology experience, predominantly treating genitourinary and lower gastrointestinal cancers. I have a particularly strong research background, with extensive experience as an investigator in clinical trials and translational research. I have completed a Masters in Clinical Epidemiology and have submitted a PhD in translational prostate cancer. Through working at the NHMRC Clinical Trials Centre and for the ANZUP Trials Group, I have developed trial management experience in large Phase 2 and 3 trials and have established solid research connections and collaborative networks.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
FORAGER-1: CTU: FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer with FGFR3 Alterations
Zhang, A. (Primary Chief Investigator), Chapman, N. (Clinical Trial Unit Staff), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Lawrie, A. (Clinical Trial Unit Staff) & Delahunt Smoleniec, J. (Clinical Trial Unit Staff)
12/11/25 → 1/02/27
Project: Research
-
IZABRIGHT-BLADDER01: CTU: IZABRIGHT-BLADDER01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy For Metastatic Urothelial Cancer in Participants with Disease Progression On Or After An Immunotherapy-based Treatment
Zhang, A. (Primary Chief Investigator), Quinlan, G. (Clinical Trial Unit Staff), Chapman, N. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), TAIDI, G. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Lawrie, A. (Clinical Trial Unit Staff) & Delahunt Smoleniec, J. (Clinical Trial Unit Staff)
22/09/25 → 21/09/30
Project: Research
-
CTU: A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)
Zhang, A. (Primary Chief Investigator), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), TAIDI, G. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Lawrie, A. (Clinical Trial Unit Staff) & Delahunt Smoleniec, J. (Clinical Trial Unit Staff)
8/07/25 → 11/06/30
Project: Research
-
NIAGARA-2: CTU: A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-Invasive Bladder Cancer
Zhang, A. (Primary Chief Investigator), Chapman, N. (Clinical Trial Unit Staff), Quinlan, G. (Clinical Trial Unit Staff), Garcia, M. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff), Chik, J. (Clinical Trial Unit Staff) & Delahunt Smoleniec, J. (Clinical Trial Unit Staff)
29/04/25 → 4/03/30
Project: Research
-
PEAR: CTU: Patient and Healthcare Practitioner PrEferences for Treatments in Advanced RCC (PEAR)
Zhang, A. (Primary Chief Investigator), TAIDI, G. (Clinical Trial Unit Staff), Quinlan, G. (Clinical Trial Unit Staff), Martin, L. (Clinical Trial Unit Staff), Armstrong, E. (Clinical Trial Unit Staff) & Chapman, N. (Clinical Trial Unit Staff)
20/03/25 → 29/08/29
Project: Research
-
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Conduit, C., Inderjeeth, A. J., Allen, R., Martin, A. J., Parulekar, W., Mulroe, E., McJannett, M., Zielinski, R. R., Thomson, A., Tan, T. H., Sandhu, S. K., Reaume, M. N., Pook, D. W., North, S. A., Marx, G. M., Joshua, A., Horvath, L., McDermott, R., Chowdhury, S. & Chi, K. N. & 5 others, , 2025, In: Future Oncology. 21, 6, p. 627-636 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus)3 Downloads (Pure) -
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Kwan, E. M., Ng, S. W. S., Tolmeijer, S. H., Emmett, L., Sandhu, S., Buteau, J. P., Iravani, A., Joshua, A. M., Francis, R. J., Subhash, V., Lee, S.-T., Scott, A. M., Martin, A. J., Stockler, M. R., Donnellan, G., Annala, M., Herberts, C., Davis, I. D., Hofman, M. S. & Azad, A. A. & 2 others, , Aug 2025, In: Nature Medicine. 31, 8, p. 2722-2736 34 p.Research output: Contribution to journal › Article › peer-review
18 Link opens in a new tab Citations (Scopus) -
Patient satisfaction with Telehealth as an element of hybrid decentralised clinical trials: a cross-sectional study of oncology clinical trial participants
Parsonson, A., Karikios, D., Park, J., Sabanathan, D., Gurney, H., Zhang, A., Gilchrist, J., Chan, W. Y., Kim, S., Harrison, W., Narayanan, S., Boyle, F. & Lau, A., Aug 2025, In: Asia-Pacific Journal of Clinical Oncology. 21, Supplement 3, p. 27-28 2 p.Research output: Contribution to journal › Meeting abstract › peer-review
-
Patient satisfaction with telehealth as an element of hybrid decentralized clinical trials (DCTs): a cross-sectional study of oncology clinical trial participants
Parsonson, A. O., Karikios, D. J., Park, J. J., Sabanathan, D., Gurney, H., Zhang, A. Y., Gilchrist, J., Chan, W. Y., Kim, S., Harrison, W., Narayanan, S., Boyle, F. M. & Lau, A. Y. S., 1 Jun 2025, In: Journal of Clinical Oncology. 43, 16 Supplement, p. E13884 1 p.Research output: Contribution to journal › Meeting abstract › peer-review
Open Access -
Perioperative chemotherapy use and related outcomes in muscle-invasive bladder cancer in Australia
Hiong, A., Lynam, J., Weickhardt, A., Wong, S., Sengupta, S., Manohar, P., Wong, L.-M., Dundee, P., Lawrentschuk, N., Zhang, A. Y., Anton, A., Raghunath, A., Gibbs, P. & Tran, B., Sept 2025, In: BJUI Compass. 6, 9, p. 1-10 10 p., e70083.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus)
Prizes
Activities
- 7 Presentation
-
An analysis of multiple biomarkers to better predict prostate cancer metastasis and death after radical prostatectomy
Zhang, A. (Speaker)
8 Feb 2018 → 10 Feb 2018Activity: Talk or presentation › Presentation
-
Chemotherapy reduces time to development of radiation-induced sarcomas
Zhang, A. (Speaker)
2 Jun 2017 → 6 Jun 2017Activity: Talk or presentation › Presentation
-
A prospective multi-centre Phase III validation study of AZGP1 as a biomarker in localized prostate cancer
Zhang, A. (Speaker)
13 Feb 2017 → 15 Feb 2017Activity: Talk or presentation › Presentation
-
Toxicity-adjusted dose of sunitinib gives low-intra-patient variation of trough levels: A longitudinal study in metastatic renal cell cancer
Zhang, A. (Speaker)
30 May 2014 → 3 Jun 2014Activity: Talk or presentation › Presentation
-
Metformin to preventing androgen deprivation therapy-induced insulin resistance and the metabolic syndrome
Zhang, A. (Speaker)
27 Sept 2013 → 1 Oct 2013Activity: Talk or presentation › Presentation